Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2014

Jan 31, 2014

29745_dirs_2014-01-30_dfa1aafb-f537-4f98-9a0a-3420daae49f6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-01-28

Reporting Person: Lundberg Jan M (EVP,Science&Tech and Pres. LRL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-28 Common Stock A 43376 $54.23 Acquired 143629 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-28 Restricted Stock Unit $ A 20985 Acquired 2015-02-01 Common Stock (20985.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 978 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.